Skip to content
Screener

Cardiol Therapeutics CRDL Q3 2025 earnings

Reported November 13, 2025 · Before market open

EPS-$0.09In line
EPS estimate-$0.09

Next report

Date not yet announced

FAQ

When did Cardiol Therapeutics report Q3 2025 earnings?
Cardiol Therapeutics (CRDL) reported Q3 2025 earnings on November 13, 2025 before market open.
What were Cardiol Therapeutics's Q3 2025 revenue and EPS?
Cardiol Therapeutics reported eps of $-0.09 for Q3 2025.
Did Cardiol Therapeutics beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.09 by $0.00.
How did Cardiol Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 30.8% from $-0.13.